People with Parkinson’s disease who show early dysfunction in the nerves controlling heartbeat tend to experience faster disease progression,…
Articles by Marisa Wexler, MS
Ventus Therapeutics and Novo Nordisk have agreed to work together to develop new anti-inflammatory medicines that may be…
Parkinson’s patients with a postural abnormality called Pisa syndrome show deficits in their ability to process visual and…
Zonisamide, an epilepsy medication approved in the U.S. for some seizure-causing disorders, may reduce the motor symptoms of Parkinson’s…
Treatment with cannabidiol (CBD) prevented nerve cell death, extended survival, and reduced toxic protein clumps in nematode worm models of…
A new online tool based on artificial intelligence could help reduce possible side effects from anticholinergic medications, a class of…
Probiotic supplements were found to ease multiple measures of constipation in people with Parkinson’s disease in a small clinical…
The use of antipsychotic medications is substantially more common among people with Parkinson’s disease than in the general population,…
Rates of blood vessel dysfunction are not significantly different in people with Parkinson’s disease compared to the general population,…
Alpha-synuclein aggregation — the toxic clumping of proteins in nerve cells that is a hallmark of Parkinson’s disease —…